Crystal structure of human legumain in complex with (2s)-n-[(3s)-5-amino-5-oxopent-1-yn-3-yl]-1-[1-[4-(cyclopropylmethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide Deposition Author(s): Bartels, B. , Benz, J. , Ehler, A. , Hewings-David, S. , Rudolph, M.G.
Date: 2022-10-05 Method: X-RAY DIFFRACTION Resolution: 2.18 Å Organism(s): Homo Sapiens Sequences Data: 7FQH_A , 7FQH_B , 7FQH_D
Crystal structure of human legumain in complex with (2s)-n-[(1s)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide Deposition Author(s): Bartels, B. , Benz, J. , Ehler, A. , Rudolph, M.G.
Date: 2022-10-05 Method: X-RAY DIFFRACTION Resolution: 1.45 Å Organism(s): Homo Sapiens Sequences Data: 7FQI_A , 7FQI_B , 7FQI_C
Crystal structure of human legumain in complex with (2s)-n-[(1s)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide Deposition Author(s): Bartels, B. , Benz, J. , Ehler, A. , Rudolph, M.G.
Date: 2022-10-05 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Homo Sapiens Sequences Data: 7FQJ_A , 7FQJ_B , 7FQJ_C
Crystal structure of human legumain in complex with (2s)-n-[(3s)-5-amino-1-(1,3-oxazol-2-yl)-5-oxopent-1-yn-3-yl]-1-[1-[4-(trifluoromethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide Deposition Author(s): Bartels, B. , Benz, J. , Ehler, A. , Rudolph, M.G.
Date: 2022-10-05 Method: X-RAY DIFFRACTION Resolution: 1.97 Å Organism(s): Homo Sapiens Sequences Data: 7FQK_A , 7FQK_B , 7FQK_C , 7FQK_D
Crystal structure of human legumain in complex with (2s)-n-[(1s)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide Deposition Author(s): Bartels, B. , Benz, J. , Ehler, A. , Rudolph, M.G.
Date: 2022-10-05 Method: X-RAY DIFFRACTION Resolution: 2.53 Å Organism(s): Homo Sapiens Sequences Data: 7FQL_A , 7FQL_B , 7FQL_C , 7FQL_D , 7FQL_E , 7FQL_F , 7FQL_G , 7FQL_H